Portfolio company
MultiplexDX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops molecular diagnostic tests and reagents for oncologists and research institutions to improve cancer profiling and infectious disease detection.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
Oncoliq
This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Diana Biotechnologies
This company develops PCR diagnostic kits and molecular biology reagents for healthcare providers, pharmaceutical partners and academic laboratories.
Biome Diagnostics
This company develops AI-powered microbiome diagnostic tools and cancer immunotherapy prediction tests for healthcare professionals, laboratories, and individual consumers.
